Clinical case of an atypical variant of Labbe's vein structure in a patient with pharmacoresistant temporal epilepsy

Pavel G. Shnyakin , Natalya V. Isaeva , Diana V. Dmitrenko , Valeria V. Roslavtseva , Anna A. Usoltseva , Evgeniy A. Ermilov , Maria K. Medvedeva , Aleksei V. Trubkin , Alexander V. Putilin , Anastasia S. Loseva

Neurology Bulletin ›› 2024, Vol. LVI ›› Issue (3) : 311 -321.

PDF (1251KB)
Neurology Bulletin ›› 2024, Vol. LVI ›› Issue (3) :311 -321. DOI: 10.17816/nb626476
Clinical case reports
research-article

Clinical case of an atypical variant of Labbe's vein structure in a patient with pharmacoresistant temporal epilepsy

Author information +
History +
PDF (1251KB)

Abstract

Among the commonly recognised structural lesions that cause drug-resistant temporal lobe epilepsy, such as mesial temporal sclerosis, focal cortical dysplasia, benign intracerebral tumors, arteriovenous malformations and cavernous angiomas, researchers have recently noted other pathologies, such as, encephalocele. There are a number of publications on the connection between epilepsy and cerebral venous angiomas. However, there are no published cases of the influence of the abnormal structure and location of normal cerebral vessels on the development of epilepsy. This article presents a case of an atypically large and unusually located vein of Labbe that may have been involved in epileptogenesis and also complicated an anteromedial temporal lobectomy. Forced coagulation and excision of the Labbe vein during surgery did not lead to venous infarction and neurological deficit.

Keywords

epilepsy / drug resistance / venous developmental anomaly / Labbe's vein

Cite this article

Download citation ▾
Pavel G. Shnyakin, Natalya V. Isaeva, Diana V. Dmitrenko, Valeria V. Roslavtseva, Anna A. Usoltseva, Evgeniy A. Ermilov, Maria K. Medvedeva, Aleksei V. Trubkin, Alexander V. Putilin, Anastasia S. Loseva. Clinical case of an atypical variant of Labbe's vein structure in a patient with pharmacoresistant temporal epilepsy. Neurology Bulletin, 2024, LVI(3): 311-321 DOI:10.17816/nb626476

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Egorova EV. Developmental venous anomalies and epilepsy. Doctor.ru. 2021;20(9):21–25. (In Russ.) EDN: UJFPOK doi: 10.31550/1727-2378-2021-20-9-21-25

[2]

Егорова Е.В. Венозные аномалии развития и эпилепсия // Доктор. Ру. 2021. Т. 20, № 9. С. 21–25. EDN: UJFPOK doi: 10.31550/1727-2378-2021-20-9-21-25

[3]

Aghayev K. Surgically treated epilepsy due to developmental venous anomaly of the brain: Case report and review of the literature. World Neurosurg. 2020;141:119–122. doi: 10.1016/j.wneu.2020.06.040

[4]

Aghayev K. Surgically treated epilepsy due to developmental venous anomaly of the brain: Case report and review of the literature // World Neurosurg. 2020. Vol. 141. Р. 119–122. doi: 10.1016/j.wneu.2020.06.040

[5]

Scheidegger O. Epileptogenic developmental venous anomaly: Insights from simultaneous EEG/fMRI. Clin EEG Neurosci. 2013; 44(2):157–160. doi: 10.1177/1550059412464463

[6]

Scheidegger O. Epileptogenic developmental venous anomaly: Insights from simultaneous EEG/fMRI // Clin EEG Neurosci. 2013. Vol. 44, N 2. Р. 157–160. doi: 10.1177/1550059412464463

[7]

Dussaule C. Can developmental venous anomalies cause seizures? J Neurol. 2017;264(12):2495–2505. doi: 10.1007/s00415-017-8456-5

[8]

Dussaule C. Can developmental venous anomalies cause seizures? // J Neurol. 2017. Vol. 264, N 12. Р. 2495–2505. doi: 10.1007/s00415-017-8456-5

[9]

Sughrue ME. Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients. J Clin Neurosci. 2011;18(5):628–632. doi: 10.1016/j.yneu.2011.05.055

[10]

Sughrue M.E. Incidence, risk factors, and outcome of venous infarction after meningioma surgery in 705 patients // J Clin Neurosci 2011. Vol. 18, N 5. Р. 628–632. doi: 10.1016/j.yneu.2011.05.055

[11]

Agrawal D. Postoperative cerebral venous infarction. J Pediatr Neurosci. 2015;10(1):5–8. doi: 10.4103/1817-1745.154314

[12]

Agrawal D. Postoperative cerebral venous infarction // J Pediatr Neurosci 2015. Vol. 10, N 1. Р. 5–8. doi: 10.4103/1817-1745.154314

[13]

Sood S. Significance of preserving the vein of Labbé in epilepsy surgery involving temporal lobe resection. J Neurosurg. 2006;105:210–213. doi: 10.3171/ped.2006.105.3.210

[14]

Sood S. Significance of preserving the vein of Labbé in epilepsy surgery involving temporal lobe resection // J Neurosurg. 2006. Vol. 105. Р. 210–213. doi: 10.3171/ped.2006.105.3.210

[15]

Silva PS. Anatomical variations of the vein of Labbé: An angiographic study. Surg Radiol Anat. 2014;36(8):769–773. doi: 10.1007/s00276-014-1264-z

[16]

Silva P.S. Anatomical variations of the vein of Labbé: An angiographic study // Surg Radiol Anat. 2014. Vol. 36, N 8. Р. 769–773. doi: 10.1007/s00276-014-1264-z

[17]

Shoman NM. Contemporary angiographic assessment and clinical implications of the vein of Labbé in neurotologic surgery. Otol Neurotol. 2011;32(6):1012–2016. doi: 10.1097/MAO.0b013e3182255980

[18]

Shoman N.M. Contemporary angiographic assessment and clinical implications of the vein of Labbé in neurotologic surgery // Otol Neurotol. 2011. Vol. 32, N 6. Р. 1012–2016. doi: 10.1097/MAO.0b013e3182255980

[19]

Mincă DI. A new classification of the anatomical variations of Labbé's inferior anastomotic vein. Tomography. 2022 30;8(5):2182–2192. doi: 10.3390/tomography8050183

[20]

Mincă D.I. A new classification of the anatomical variations of Labbé's inferior anastomotic vein // Tomography. 2022. Vol. 30, Vol. 8, N 5. Р. 2182–2192. doi: 10.3390/tomography8050183

[21]

Krylov VV, Lyunkova RN. Surgical anatomy of the Labbe vein. Neurosurgery. 2020;22(3):14–22. (In Russ.) EDN: WZYJAN doi: 10.17650/1683-3295-2020-22-3-14-22

[22]

Крылов В.В., Люнькова Р.Н. Хирургическая анатомия вены // Нейрохирургия. 2020. Т. 22, № 3. С. 14–22. EDN: WZYJAN doi: 10.17650/1683-3295-2020-22-3-14-22

[23]

Bekov DB, Mikhailov SS. Atlas of arteries and veins of the human brain. Moscow: Medicine; 1979. 287 р. (In Russ.)

[24]

Беков Д.Б., Михайлов С.С. Атлас артерий и вен головного мозга человека. Москва: Медицина, 1979. 287 с.

[25]

Lang J. Skull base and related structures: Atlas of Clinical Anatomy. New York: Schattauer-Verlag; 2001. p. 103–116.

[26]

Lang J. Skull base and related structures: Atlas of Clinical Anatomy. New York: Schattauer-Verlag, 2001. p. 103–116.

[27]

Jagtap SA. Temporal encephalocele: A rare but treatable cause of temporal lobe epilepsy. Epileptic Disord. 2022;24(6):1073–1080. doi: 10.1684/epd.2022.1487

[28]

Jagtap S.A. Temporal encephalocele: A rare but treatable cause of temporal lobe epilepsy // Epileptic Disord. 2022. Vol. 24, N 6. Р. 1073–1080. doi: 10.1684/epd.2022.1487

[29]

Saavalainen T. Temporal anteroinferior encephalocele: An underrecognized etiology of temporal lobe epilepsy? Neurology. 2015;85(17):1467–1474. doi: 10.1212/WNL.0000000000002062

[30]

Saavalainen T. Temporal anteroinferior encephalocele: An underrecognized etiology of temporal lobe epilepsy? // Neurology. 2015. Vol. 85, N 17. Р. 1467–1474. doi: 10.1212/WNL.0000000000002062

[31]

Collard E, Byrne C, Georgiou M, et al. Joubert syndrome diagnosed renally late. Clin Kidney J. 2020;14(3):1017–1019. doi: 10.1093/ckj/sfaa007

[32]

Collard E., Byrne C., Georgiou M., et al. Joubert syndrome diagnosed renally late // Clin Kidney J. 2020. Vol. 14, N 3. Р. 1017–1019. doi: 10.1093/ckj/sfaa007

[33]

Gana S, Serpieri V, Valente EM. Genotype-phenotype correlates in Joubert syndrome: A review. Am J Med Genet C Semin Med Genet. 2022;190(1):72–88. doi: 10.1002/ajmg.c.31963

[34]

Gana S., Serpieri V., Valente E.M. Genotype-phenotype correlates in Joubert syndrome: A review // Am J Med Genet C Semin Med Genet. 2022. Vol. 190, N 1. Р. 72–88. doi: 10.1002/ajmg.c.31963

[35]

Boling WW. Surgical considerations of intractable mesial temporal lobe epilepsy. Brain Sci. 2018;8(2):35. doi: 10.3390/brainsci8020035

[36]

Boling W.W. Surgical considerations of intractable mesial temporal lobe epilepsy // Brain Sci. 2018. Vol. 8, N 2. Р. 35. doi: 10.3390/brainsci8020035

[37]

Nasyrova RF, Sivakova NA, Lipatova LV, et al. Biological markers of the antiepileptic drugs efficacy and safety: pharmacogenetics and pharmacokinetics. Siberian Medical Review. 2017;(1):17–25. EDN: YHZUEJ doi: 10.20333/2500136-2017-1-17-25

[38]

Насырова Р.Ф., Сивакова Н.А., Липатова Л.В., и др. Биологические маркёры эффективности и безопасности противоэпилептических препаратов: фармакогенетика и фармакокинетика // Сибирское медицинское обозрение. 2017 № 1. С. 17–25. EDN: YHZUEJ doi: 10.20333/2500136-2017-1-17-25

RIGHTS & PERMISSIONS

Eco-Vector

PDF (1251KB)

163

Accesses

0

Citation

Detail

Sections
Recommended

/